Mechanisms of ErbB2-mediated paclitaxel resistance and trastuzumab-mediated paclitaxel sensitization in ErbB2-overexpressing breast cancers
- 31 October 2001
- journal article
- Published by Elsevier in Seminars in Oncology
- Vol. 28, 12-17
- https://doi.org/10.1016/s0093-7754(01)90277-5
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: